Research Site

Cary, North Carolina 27518

3 studies enrolling now · 18 studies all time

What they study most

APOL1-Mediated Kidney Disease, Asthma, Atherothrombosis, Cardiovascular Death, Diabetes Mellitus, Type 2, Dyslipidemia, Elevated High-sensitivity C-Reactive Protein (hsCRP), Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD), Erectile Dysfunction, Gastroesophageal Reflux Disease (GERD), Heart Failure, Migraine Disorders

Studies at this site

• A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin — Recruiting now
• Anifrolumab Pregnancy Study — Recruiting now
• Dose-Ranging Safety, Tolerability, and Efficacy Study of AZD2373 in Participants With APOL1-Mediated Kidney Disease — Recruiting now
• Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk — Completed
• Registrational Study With Omecamtiv Mecarbil (AMG 423) to Treat Chronic Heart Failure With Reduced Ejection Fraction — Completed
• Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia — Completed
• A Multicenter Assessment of ALD403 in Chronic Migraine — Completed
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus — Completed
• Tecfidera Slow-Titration Study — Stopped early
• A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents — Completed
• Zomig - Treatment of Acute Migraine Headache in Adolescents — Completed
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin — Completed
• Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes — Completed
• JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events — Stopped early
• Long-Term Safety and Efficacy Study of Avanafil in Men With Erectile Dysfunction — Completed
• Research Evaluating an Investigational Medication for Erectile Dysfunction - Diabetic ED (REVIVE-D) — Completed
• Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED — Completed
• Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US — Completed